Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 14, Issue 3, Pages 275-285
Publisher
Informa UK Limited
Online
2018-02-13
DOI
10.1080/17425255.2018.1440287
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate
- (2018) Izna Ali et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Towards personalized treatment of pain using a quantitative systems pharmacology approach
- (2017) Sebastiaan C. Goulooze et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Evidence-based drug treatment for special patient populations through model-based approaches
- (2017) Elke H.J. Krekels et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- The effect of morbid obesity on morphine glucuronidation
- (2017) Celia Lloret-Linares et al. PHARMACOLOGICAL RESEARCH
- Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot Study
- (2017) Janelle D. Vaughns et al. PEDIATRIC DRUGS
- Obesity and kidney disease: Hidden consequences of the epidemic
- (2017) CP Kovesdy et al. Physiology International
- Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients
- (2016) Abdulaziz S. Alobaid et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of concomitant medications on obstructive sleep apnoea
- (2016) Ingrid Jullian-Desayes et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers
- (2016) Kalayanee Chairat et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
- (2016) Elisa A. M. Calvier et al. CLINICAL PHARMACOKINETICS
- Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen
- (2016) Anne van Rongen et al. CLINICAL PHARMACOKINETICS
- Trends in Obesity Among Adults in the United States, 2005 to 2014
- (2016) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Microdialysis as a way to measure antibiotics concentration in tissues
- (2016) Sandrine Marchand et al. PHARMACOLOGICAL RESEARCH
- Drug Disposition in Obesity: Toward Evidence-Based Dosing
- (2015) Catherijne A.J. Knibbe et al. Annual Review of Pharmacology and Toxicology
- Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice
- (2015) A. Smits et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents
- (2015) Anne van Rongen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis
- (2015) BC Ferslew et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Targeting xenobiotic receptors PXR and CAR in human diseases
- (2015) Monimoy Banerjee et al. DRUG DISCOVERY TODAY
- The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery
- (2015) Margreke J. Brill et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or ConfirmedStaphylococcus aureusInfections
- (2015) Eyob D. Adane et al. PHARMACOTHERAPY
- Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers
- (2014) Margreke J. E. Brill et al. CLINICAL PHARMACOKINETICS
- Effect of a Roux-en-Y Gastric Bypass on the Pharmacokinetics of Oral Morphine Using a Population Approach
- (2014) Célia Lloret-Linares et al. CLINICAL PHARMACOKINETICS
- Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint
- (2014) Jeroen Diepstraten et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition
- (2014) Lori WE van der Schoor et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects
- (2013) Podjanee Jittamala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects
- (2013) M Ulvestad et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis
- (2013) M. J. E. Brill et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors
- (2012) Tatiana F.S. Teixeira et al. CLINICAL NUTRITION
- Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
- (2012) Margreke J.E. Brill et al. CLINICAL PHARMACOKINETICS
- Maturation of the Glomerular Filtration Rate in Neonates, as Reflected by Amikacin Clearance
- (2012) Roosmarijn F.W. De Cock et al. CLINICAL PHARMACOKINETICS
- Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
- (2012) Christophe Bardin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Obesity and the risk and outcome of infection
- (2012) R Huttunen et al. INTERNATIONAL JOURNAL OF OBESITY
- Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2012) Jennifer J. Griggs et al. JOURNAL OF CLINICAL ONCOLOGY
- Obesity and Allometric Scaling of Pharmacokinetics
- (2011) Douglas J. Eleveld et al. CLINICAL PHARMACOKINETICS
- Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients
- (2011) Simone van Kralingen et al. CLINICAL PHARMACOKINETICS
- Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
- (2011) Keith A. Rodvold et al. CLINICAL PHARMACOKINETICS
- Implications of Obesity for Drug Therapy: Limitations and Challenges
- (2011) R Jain et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Alteration of Hepatic but Not Renal Transporter Expression in Diet-Induced Obese Mice
- (2011) V. R. More et al. DRUG METABOLISM AND DISPOSITION
- Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients
- (2011) M. G. Kees et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial)
- (2011) L. M. Thorne-Humphrey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- On the Accuracy of Estimation of Basic Pharmacokinetic Parameters by the Traditional Noncompartmental Equations and the Prediction of the Steady-State Volume of Distribution in Obese Patients Based Upon Data Derived from Normal Subjects
- (2011) Leonid M. Berezhkovskiy JOURNAL OF PHARMACEUTICAL SCIENCES
- Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters
- (2011) Romi Ghose et al. LIFE SCIENCES
- Impaired Pharmacokinetics of Levothyroxine in Severely Obese Volunteers
- (2011) Marina A. Michalaki et al. THYROID
- Estimating the Glomerular Filtration Rate in Obese Adult Patients for Drug Dosing
- (2010) Manjunath P. Pai ADVANCES IN CHRONIC KIDNEY DISEASE
- Lean Body Weight Scalar for the Anesthetic Induction Dose of Propofol in Morbidly Obese Subjects
- (2010) Jerry Ingrande et al. ANESTHESIA AND ANALGESIA
- Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients
- (2010) Simone Van Kralingen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
- Estimation of creatinine clearance in morbidly obese patients
- (2009) Jasmina A. Demirovic et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Should Dosing of Rocuronium in Obese Patients Be Based on Ideal or Corrected Body Weight?
- (2009) Christian S. Meyhoff et al. ANESTHESIA AND ANALGESIA
- Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats
- (2009) Craig D. Fisher et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery
- (2009) April Barbour et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hepatic Microcirculation in Fatty Liver Disease
- (2008) Geoff C. Farrell et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Lean body mass normalizes the effect of obesity on renal function
- (2008) Sarayut Janmahasatian et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption
- (2008) A. Chagnac et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now